TABLE-Shionogi <4507.T>-6mth group results
Nov 4 (Reuters) -
SHIONOGI & CO LTD
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Full year to Full year ended
Sep 30, 2009 Sep 30, 2008 Mar 31, 2010 Mar 31, 2009
LATEST YEAR-AGO COMPANY YEAR-AGO
H1 RESULTS H1 RESULTS FORECAST RESULTS Sales 132.64 105.06 280.00
(+26.3 pct) (+23.1%) Operating 17.84 18.46 60.00
(-3.4 pct) (+87.4%) Recurring 16.40 18.97 58.00
(-13.6 pct) (+81.2%) Net 11.59 11.84 35.00
(-2.1 pct) (+123.5%) EPS Y34.61 Y35.32 Y104.49 Annual div Y36.00 Y28.00 -Q2 div Y18.00 Y14.00 -Q4 div Y14.00 Y18.00
NOTE - Shionogi & Co Ltd is a major pharmaceutical maker with antibiotics as mainline.
For latest earnings estimates made by Toyo Keizai, please double click on 4507.TK1.
© Thomson Reuters 2009 All rights reserved
Dubai Debt Fears
Banks outside the Gulf played down their exposure to Dubai debt, after fears the emirate could default and even derail world economic recovery prompted a sell-off in global markets. Full Article | Slideshow
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage
India
US
UK
